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ABSTRACT 
Obstetrical ultrasound screening has taken a principal role nowadays in obstetrics and gynecology practice. It has 
captured in a way even medical professionals’ thoughts besides general population attention of having done such 
examination. With the revolutionary progress of technology the ultrasound machine itself offers tremendously 
stunning images from two dimensional, three dimensional and now has become routine even four dimensional 
ultrasound examination, bringing clinical practice to a level of excellence patient care delivery.  
The obstetrical clinical practice in Albania, pregnant women are suggested routinely the combination of 
obstetrical ultrasound examination with biochemical markers. A nuchal translucency (NT) more than 3 mm is 
associated with an increased risk of structural fetal abnormalities, fetal heart abnormalities, subsequent 
pregnancy loss, and other. Double, triple and quadruple test are accessibility and commonly biochemical markers 
done as complementary tests to ultrasound screen in early detection fetal anomalies in our clinical practice. 
In conclusion, nowadays medical practice in obstetrics and gynecology has adopted the classic and modern 
aspects in order to offer a superior care to patients. The application of up to date technology in medicine such as 
obstetrical ultrasound examination and laboratory tests combined with permanent professionals’ continuing 
education offer a better not to say a gold standard assessment tool of probably diagnosis. Patients need to be 
counseled about the positive and negative findings that ultrasound and laboratory tests may reveal so they are 
prepared for unexpected pregnancy knowledge and the possibility of further testing options being offered. 
Consequently, a well organized national health care with a universal medical services proper training and 
employ of assets sustain our mother and child care service to western standards.   
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Introduction 
Obstetrical ultrasound examination principally is influenced by two essential factors, first the component of 
human resources such as a proficient examiner which takes time and expenses in addition to everlasting 
education and practice, second component is the machine itself with all the supplementary elements that consist 
of. Many aspects of antenatal care attendance means have changed in the past few generations. Today, the 
availability of proper preconception and prenatal care such as early screening, assessment and diagnostic tests, 
parents are given a chance to prepare themselves for the possibility that their child might be born disabled and to 
educate themselves about the options. Although the primary aim of first trimester screening is to identify 
pregnancies at risk of aneuploidy, first trimester findings may give insight into other adverse pregnancy 
outcomes.  
The mainstay of antenatal non invasive screening of the first and second trimester are serum biochemical 
markers commonalty namely; double, triple and quadruple test combined with ultrasound markers explicitly; 
nuchal translucency (NT), absent nose bone, dilated brain ventricles, spina bifida and other. Structural fetal 
abnormalities have significant short and long term impact in health care services and socially in broad spectrum. 
The practical approach to interpreting abnormal first trimester findings and assess what further testing may be 
indicated should include a multidisciplinary manner. Abnormalities discussed in this article will include: I. 
Nuchal translucency, II. Abnormal fetal anatomy detected at first trimester screening and III. Abnormal maternal 
serum analytes in addition to a harmonized consultation of multidisciplinary experts by respective medical 
disciplines 
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Discussion    
Nuchal Translucency 
 
As in many other fields in medicine we do refer our data to the national and international guidelines; evidence 
based medicine is today an additional polar star which guides us in addition to our theoretical and practical 
knowledge and experience in making proper assessment, diagnosing and management. So far there are accepted 
as normal range of nuchal translucency (NT) less than 3 mm, of course taken into strict consideration adequately 
assessed favorable fetal lie and gestational age CRL 45 – 84 mm [1, 2, 3, 5]. Thickened NT has been associated 
with a numerous of syndromes, nevertheless most of these have only been reported very few in the literature [2].  
 
In our clinical practice do offer relatively the same standards as in western clinics in regards to obstetrical 
ultrasound examination such as the measurements of NT and laboratory tests. The question is; how we keep 
away our professional integrity from marketing of medicine? In a way rather than giving to the patients proper 
professionally care we do overstress them during a natural process that has been taken place since mankind 
presence on earth. Consequently, unless a specific medical family history is present that tips to an amplified 
likelihood of explicit disorder, it is unlikely to be clinically reasonable to counsel patients regarding all these rare 
possibilities. On the other hand, having these means of assessment and diagnostic, we should be cautious and 
keep in mind that human assets dominate the decision subsequent to the ultrasound and laboratory findings and 
deliver the information to the patients in a wised professional manner. 
 
Abnormal fetal anatomy detected at first trimester screening 
 
Before the health technology era in clinical practice which encompasses a broad range of healthcare products 
used to assess, diagnose, monitor or even treat diseases or medical conditions affecting humans, we did not have 
many options to conclude to a fetal abnormal anatomy diagnosis other than professional medical knowledge 
applied into clinical practice. 
 
Development begins at fertilization followed by cleavage of embryo and its implantation in uterus which takes 
time from day one to first week, pursued by the differentiation of the primary germ layers and culminates in 
primary organogenesis when tissues and major organ rudiments of embryonic body are formed by eight week. In 
Albania we do see in our clinical practice most of pregnant women around eight to nine weeks after the first day 
of last menstrual periods, yet the latest literature do mention the importance of early antenatal visit [4, 5, 6, 7]. 
Early stages of embryo development shown in figure 1 and stages from fertilization to twelve weeks described in 
figure 2.   
 
Figure 1.            Figure 2. 
 
 
Some of structural fetal abnormalities are visible during first trimester of pregnancy from eleven to thirteen 
weeks and six days. We do offer obstetrical ultrasound examination during the first and second trimester in our 
obstetrical clinical practice in Albania such; nuchal translucency measurement and later on the detailed 
anatomical obstetrical ultrasound examination up to twenty four weeks of gestation. In the mean time we assess 
other obstetrical ultrasound soft markers; face (visualization of nose, nasal bone, orbits, lips), skull and brain 
(skull ossification, lateral ventricles, cerebellum, cistern magna, cavum septi pellucidi), anencephaly, 
encephalocele, explore for occurrence of cystic hygroma, spine (search for presence of neural tube in 
longitudinal and transverse view, heart (rhythm of fetal heart, four chamber view, and assessment of great 
vessels), genitourinary (presence, size and shape of kidneys; existence, size and shape of urinary bladder; 
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presence of genital organs), gastrointestinal (stomach and bowel, abdominal wall and umbilical vessels as well), 
extremities (evaluate extremities, and digits). When visualization of fetal structures is not optimal or a structural 
abnormality is suspected during transabdominal scan, transvaginal scan is always performed. Some of abnormal 
fetal anatomy diagnosed at our medical center are; an increased nuchal translucency - Figure 3, cystic hygroma 
at 12-13 weeks of pregnancy - figure 4, Dandy Walking malformation - figure 5. 
                   Figure 3.     Figure 4.  Figure 5. 
   
Abnormal maternal serum analytes 
Serum biochemical markers are requested routinely in a way at our clinical setting, the first trimester 
biochemical screening in combination with obstetrical ultrasound findings are suggested two markers or as 
frequently called double test (beta-human chorionic gonadotropin β-hCG and pregnancy associated plasma 
protein A – PAPP-A) both measured from eleven to thirteen weeks and six days accordingly crown-rump length 
up to 84 mm. Second trimester serum biochemical screen consist of triple test (AFP, hCG, and unconjugated 
estriol-UE3) and measurement of an additional  hormone levels to triple test known as inhibin A which is 
released by placenta is called quadruple test. These two last tests are done from 15th – 22nd weeks, however in 
order to obtain most accurate values we suggest to be done between 16th and 18th weeks of gestation. 
Countless factors affect levels of maternal serum analytes which ought to be taken into consideration when 
calculating risks. These include; previous screening results, gravidity and parity, smoking, alcohol and other 
substance abuse, previous or present harmful exposure, assisted reproduction, pregnancy complications, maternal 
age, weight and diabetic status. Screening test suggested in first and second trimester of pregnancy identify 
pregnant women mainly as high risk or low risk, where in the high risk group is proceeded to diagnostic 
procedures, and in low risk group keep on regular assessment. So in the other words, positive results in these 
screening test only places the pregnant women to a high risk group and does not in any way imply decisively that 
fetus is affected with abnormalities. 
Conclusions and Recommendations 
Maternal and child health is one of the most important indicators of any country national health standards. 
Continuous professional medical education of human resources together with application of up to date assets and 
technology in clinical practice will bring short and long term impact to a better health service delivered to 
population. Proficient medical knowledge in cooperation with appropriate interpretation of obstetrical ultrasound 
examination findings and laboratory test results will aid pregnant women and their loved ones to make an 
informed decision throughout pregnancy.  
A well-organized national health care service with a universal medical system, proper training and utilization of 
assets withstand our mother and child care service to western standards 
 
Finally, suggested recommendations are:  
1. Albanian professional license of obstetrical ultrasound practitioners must express the proficiency level 
of exam interpretation. 
2. The privileged professionals exercising this medical practice must be licensed and accredited by a 
recognized western university clinic/center of fetal medicine. 
3. Multi-disciplinary consultation in accordance with patients and/or her family should make the final 
informed decision of any fetal malformation over 12 weeks of gestation.     
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